Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07548541
NA

Acute Effects of Creatine and L-Arginine Co-Supplementation on Anaerobic and Cognitive Performance in Recreationally Active Males

Sponsor: Inonu University

View on ClinicalTrials.gov

Summary

This randomized, double-blind, four-period crossover trial investigates the acute effects of creatine monohydrate, L-arginine, and their combined administration on anaerobic performance, jump performance, and cognitive reaction time in recreationally active adult males. Eighteen healthy male participants complete four experimental conditions in randomized order: placebo, creatine, L-arginine, and creatine plus L-arginine, with at least 72 hours between sessions. Sixty minutes after supplementation, participants perform the Stroop Color-Word Test, countermovement jump test, and Running-Based Anaerobic Sprint Test. Primary outcomes include peak power, average power, countermovement jump height, and incongruent Stroop reaction time. The study aims to determine whether acute co-supplementation produces greater ergogenic and cognitive benefits than either supplement alone or placebo.

Official title: Acute Effects of Creatine and L-Arginine Co-Supplementation on Anaerobic Power, Jump Performance, and Cognitive Reaction Time in Recreationally Active Males: A Randomized Crossover Trial

Key Details

Gender

MALE

Age Range

18 Years - 30 Years

Study Type

INTERVENTIONAL

Enrollment

18

Start Date

2025-04-01

Completion Date

2025-05-16

Last Updated

2026-04-23

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

Creatine Monohydrate

Acute oral creatine monohydrate supplementation at 0.3 g/kg body mass.

DIETARY_SUPPLEMENT

L-Arginine

Acute oral L-arginine supplementation at a dose of 6 g.

OTHER

Placebo

Placebo beverage containing 6 g sucrose dissolved in 250 mL of water.

Locations (1)

Inonu University, Faculty of Sport Sciences

Malatya, Malatya, Turkey (Türkiye)